Harnessing the Media to Advance the Global Fight Against Sepsis (Session 15 – 4th WSC)
Session 15 from the 4th World Sepsis Congress. To go directly to a specific speaker/talk, please use these chapter markers:

00:00 Intro
00:34 Lord Michael Grade – Introduction
04:12 Katelyn Jetelina – Healthcare in the Media: The Good, The Bad, and The Ugly
07:20 Joachim Mueller-Jung – How to Target Specific Audiences for Improved Medical Messaging About Sepsis
12:35 Naoyuki Matsuda – Effective Strategies for Better Medical Messaging in Media: Asia-Pacific
17:26 Immaculate Forgwe – What Is the Role of the Journalist in Amplifying Positive Medical Messaging?
21:25 Pedmia Shatu Tita – Effective Strategies for Better Medical Messaging in Media: Sub-Saharan Africa
26:09 Discussion by the Panelists

All talks are also available as a podcast – just search for World Sepsis Congress in your podcast app of choice.
Direct link: https://podcasts.apple.com/us/podcast/4th-world-sepsis-congress/id1155062518

Session 16 will be available momentarily. This concludes the 4th WSC – thanks for your interest over the last weeks. World Sepsis Congress will return with the 2024 WSC Spotlight in April 2024.

Thanks for watching and sharing.

The 4th World Sepsis Congress – One Global Health Threat: Sepsis, Pandemics, and Antimicrobial Resistance is a project by the Global Sepsis Alliance, initiator of World Sepsis Day and World Sepsis Congress.

Stop Sepsis – Save Lives

Access Non-GMO, antigen-free, generic antiviral medication formulas used in Moderna's Spikevax.

VirusTC is a retail provider of concentrated generic antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, Mayo Clinic, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.